IN THE NEWS

BOTHELL, Wash., Jul 14, 2008 (BUSINESS WIRE) – Cardiac Science today announced the launch of its HeartCentrix® 6.2 data management product for the physician office. HeartCentrix is the only solution that connects Burdick® and Quinton® equipment to an EMR system, giving access to test results remotely and across locations with a single sign-on from within the EMR itself. Cardiac Science (NASDAQ:CSCX) is a global leader in advanced cardiac diagnosis, resuscitation, rehabilitation, and informatics products.

"With HeartCentrix, our GEMMS ONE® electronic medical record (EMR) system now provides immediate access to patient information and we don't have to worry about losing the hard copy of test results," said Dr. David Griffen from Heart Clinic Arkansas. "If a patient suddenly presents with chest pain, we can go to his electronic chart immediately for the critical information we need. It's all right there at our fingertips."

HeartCentrix saves time and paper, eliminates errors, helps to ensure patient safety, and communicates bi-directionally with many Burdick and Quinton devices. The 6.2 version offers four new features versus the prior release, namely:

• HeartCentrix 6.2 interfaces with the Burdick Universal ECG, a PC-based ECG solution;
• HeartCentrix 6.2 is certified with the Allscripts® UAI interface;
• HeartCentrix 6.2 supports VISTA and remains Windows® compatible; and
• HeartCentrix 6.2 allows local printing, supplementing EMR systems' printing capabilities.

"Connectivity is becoming more important in cardiac diagnostic testing," began Rene Mitchell, director of diagnostic marketing for Cardiac Science. "In fact, connectivity is so important that all our Burdick Atria® 3100 or 6100 ECG devices now come with Ethernet communications as a standard option. Cardiac Science is always seeking to provide greater value to our customers--and this new HeartCentrix release is one more way we meet that goal."

HeartCentrix is easy to understand and use. Its familiar Windows-based interface flows left to right in a logical progression. Using a single sign-on from within the EMR, users can download orders and patient demographics directly to Burdick and Quinton diagnostic devices, upload results back to the EMR after tests are performed, and review and edit test results at the office or any remote location.

About Cardiac Science

Cardiac Science, a wholly owned subsidiary of Opto Circuits (India) Ltd., develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators (AED), electrocardiograph devices (ECG/EKG), cardiac stress treadmill and systems, PC-based diagnostic workstations, Holter monitoring systems, hospital defibrillators, vital signs monitors, cardiac rehabilitation telemetry systems, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other information systems. The company sells a variety of related products and consumables and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick^®, HeartCentrix^®, Powerheart^®, and Quinton^® brands, is headquartered in Bothell, Washington. With customers in almost 100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 425.402.2000 or visit http://www.cardiacscience.com.

Forward-Looking Statements

This press release contains forward-looking statements. The words "believe," "expect," "intend," "anticipate," variations of such words, and similar expressions identify forward-looking statements, but their absence does not mean that the statement is not forward-looking. Forward-looking statements in this press release include, but are not limited to, those relating to Cardiac Science Corporation's future AED sales in Japan, expected shipments of backordered products in the fourth quarter of 2010, and expectations regarding the closing of the transaction with Opto Circuits. These are forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results and performance may vary significantly from those expressed or implied in such statements. Factors that could cause or contribute to such varying results and other risks include those more fully described in the Annual Report on Form 10-K filed by Cardiac Science Corporation for the year ended December 31, 2009, as updated by subsequent quarterly reports on Form 10-Q. Cardiac Science Corporation undertakes no duty or obligation to update the information provided herein.

For updates and information on worldwide defibrillation and cardiac monitoring, find us on Facebook at http://facebook.com/cardiacscience, the Cardiac Science blog at http://www.cardiacscience.com/blog, Twitter at http://twitter.com/cardiacscience, and YouTube at http://budurl.com/CSonYT

For more information, contact (media) info@cardiacscience.com | (investors) ir@optoindia.com | +91.80.2852.8088

Copyright Business Wire 2008

News Provided by COMTEX